Home » Healthcare » Peripheral Artery Disease Market

Peripheral Artery Disease Market By Treatment Type (Devices, Catheters, Drugs, Others) By Route of Administration (Oral, Parenteral, Others)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Price: $4999

Published: | Report ID: 18850 | Report Format : PDF

Key Highlights of the Report

The global peripheral artery disease market is divided into four sections: material, application, distribution channel, and geography. The oral segment is the market’s most popular and in-demand segment. Hospitals and specialist clinics are the two key user groupings. Catheter segment is expected to grow at a high CAGR. Retail pharmacy and hospital pharmacy continue to hold a sizable market share, with North America dominating the market expansion.

A growing geriatric population, as well as better insurance and reimbursement policies, are driving the global peripheral artery disease market. Furthermore, treatment is expensive, and there is underdiagnosis and a lack of awareness. However, the market confronts substantial hurdles, including as patients and healthcare providers being unaware of PAD, and treatment choices being too expensive.

Nonetheless, the worldwide peripheral artery disease market offers considerable development opportunities, owing to rising demand for non-invasive treatment alternatives and technological advancements. Furthermore, novel therapeutic development.

Market Overview

The worldwide peripheral artery disease market has grown steadily in recent years and is predicted to increase at an 8.80% CAGR between 2023 and 2030. In 2022, the market was valued at USD 3.9 billion, and it is predicted to reach USD 7.0 billion by 2030.

What Are the Primary Forces Driving the Global Peripheral Artery Disease Market?

A growing geriatric population, as well as better insurance and reimbursement policies, are driving the global peripheral artery disease market.

What Are the Global Peripheral Artery Disease Market’s Major Challenges?

Patients and healthcare providers are uninformed about PAD, and treatment options are expensive, therefore the worldwide peripheral artery disease market confronts various hurdles.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

What Are the Opportunities for Growth in the Global Peripheral Artery Disease Market?

The global peripheral artery disease market is poised for significant development, thanks to rising demand for non-invasive treatment alternatives and technological advancements.

Executive Summary

Overview of the Global Peripheral Artery Disease Market

The Peripheral Artery Disease (PAD) Market refers to the market for Peripheral Artery Disease diagnosis, treatment, and management. Medical equipment, medicines, and other therapy modalities utilized in the diagnosis and treatment of PAD are included in this market. The increased prevalence of PAD, rising desire for non-invasive treatment alternatives, developments in medical technology, and rising healthcare spending are driving the market. The industry also confronts hurdles such as a lack of awareness about PAD among patients and healthcare providers, as well as treatment alternatives that are expensive. The market is likely to expand in the next years as a result of increased emphasis on the development of novel treatment alternatives and rising demand for home healthcare services.

Market Definition

Peripheral artery disease is a common cardiovascular issue that causes the peripheral arteries to narrow. It mostly affects the arteries in the legs, but it can also affect the arteries that bring blood from the heart to the arms, kidneys, head, and stomach. It is mostly caused by fat or plaque accumulation in the arterial walls. The major treatments for this condition include exercise, smoke cessation, and a good diet; however, when these treatments are insufficient, medication or surgery might be beneficial.

Peripheral Artery Disease Market

Market Insights

  • The global demand for peripheral artery disorders was worth USD 3.9 billion in 2022 and is predicted to reach USD 7.0 billion by 2030, expanding at an 8.80% CAGR between 2023 and 2030.
  • the catheter segment is anticipated to expand at a rapid CAGR, while Device is predicted to have the biggest market share.
  • The oral segment is the market’s most popular and in-demand segment, parenteral segment’s market demand is predicted to be lower than that of the oral route of administration.
  • Hospitals have a market share of approximately 60.4% in 2022, while Specialty clinic holds its significant share in the market.
  • Retail pharmacy maintains a substantial market share in 2022.
  • North America will command a share of almost 40% of the market for Peripheral Artery Disease market (PAD), while Europe is the second-largest market for PAD market and the Asia Pacific market is anticipated to develop at the highest CAGR.
  • The primary market drivers are an increase in the geriatric population and better insurance and reimbursement policies.
  • At the same time, treatment is expensive, and there is underdiagnosis and a lack of awareness.
  • The market’s primary possibilities include the growing desire for non-invasive treatment options and developments in medical technology.

Segmentation by Treatment Type

  • The catheter segment is anticipated to expand at a rapid CAGR.
  • Device is predicted to have the biggest market share.

Segmentation by Route of Administration

  • The oral segment is the market’s most popular and in-demand segment.
  • The parenteral segment’s market demand is predicted to be lower than that of the oral route of administration.

Segmentation by End-Users

  • Hospitals have a market share of approximately 60.4% in 2022.
  • Specialty clinic holds its significant share in the market.

Segmentation by Distribution Channel

  • Retail pharmacy maintains a substantial market share in 2022.
  • Hospital pharmacies have a reduced market share.

Segmentation by Region

  • In 2022, North America will command a share of almost 40% of the market for Peripheral Artery Disease (PAD).
  • Europe is the second-largest market for PAD market.
  • The Asia Pacific market is anticipated to develop at the highest CAGR.
  • The rest of the World, including Latin America, The Middle East, and Africa, contributes the remainder to the demand for peripheral artery diseases.

The rising demand for peripheral artery illnesses might be related to an aging population as well as better insurance and reimbursement policies. However, the market is hampered by the high expense of treatment, as well as underdiagnosis and a lack of awareness.

Because of the increasing frequency of PAD, rising healthcare expenditures, and the presence of important market participants in the region, North America is the largest market for PAD. Because of the high prevalence of PAD and the presence of a well-established healthcare system, the United States is the major contributor to the North American market. Europe is the second-largest market for PAD, owing to a growing older population and increased awareness of the disease. Germany, France, and the United Kingdom are the largest contributors to the European market.

Due to the increased prevalence of PAD, rising healthcare costs, and rising desire for non-invasive treatment options, the Asia Pacific market is anticipated to develop at the highest CAGR. The three countries that contribute most to the Asia Pacific market are China, India, and Japan. Due to the increased emphasis on the development of novel medicines and the growing demand for home healthcare services, the markets in Latin America, the Middle East, and Africa are also anticipated to expand. The Middle East and Africa market is dominated by Saudi Arabia, South Africa, and the United Arab Emirates, while the Latin America market is primarily influenced by Brazil, Mexico, and Argentina.

Overall, a growing geriatric population as well as better insurance and reimbursement practices are to blame for the rising demand for peripheral artery illnesses.

Geriatric Population Increase

Peripheral Artery Disease (PAD) is a common circulation condition that affects the blood vessels that are located outside of the heart and brain. The global prevalence of PAD is rising, and the growing senior population is a major contributor to this trend. The elderly are more likely to develop PAD due to the accumulation of fatty deposits in their arteries, which leads to blood vessel narrowing. The global population of persons aged 65 and up is anticipated to nearly double from 703 billion in 2019 to 1.5 billion by 2050, according to the United Nations. This demographic transition is likely to fuel the growth of the PAD market by increasing demand for PAD treatment options such as pharmacological therapies and medical devices.

As a result, pharmaceutical and medical device businesses are investing in the creation of novel goods in order to address the increasing demand from the aged population.

Improved Insurance And Reimbursement Policies

Many emerging countries, like Brazil, China, and India, are now debating whether to establish mandatory health insurance systems in order to attract greater money to the healthcare business. Furthermore, governments around the world seek to provide their residents with high-quality healthcare. Authorities work efficiently to increase public welfare through encouraging health insurance, constructing a robust infrastructure, and improving public knowledge of health-related concerns.

Additionally, all individuals now have access to critical public health services through primary care institutions. These are free at the point of delivery and are supported jointly by the federal and municipal governments. An enhanced public health package was developed with an emphasis on the health of elderly people and rural women, incorporating health education, noncommunicable diseases, and mental illnesses. Furthermore, a lot of insurance companies have expanded their market reach by making these operations accessible in the developing globe.

Treatment Is Expensive

Peripheral Artery Disease (PAD) is a chronic illness that necessitates long-term management and therapy. The expense of PAD treatment can be a substantial barrier for patients, particularly in low- and middle-income countries. The high cost of PAD therapy is mostly due to the expense of medical devices such as stents and angioplasty balloons, as well as the cost of medication. For example, the cost of PAD medication therapy might range from $4,000 to $10,000 per year. Furthermore, the expense of surgical procedures such heart bypass surgery can be excessively expensive for many individuals. The high expense of PAD therapy restricts access to care, particularly for those without health insurance or those living in countries with inadequate healthcare resources.

As a result, the patient population seeking treatment for PAD is very small, thus limiting the PAD market’s growth. Medical device and pharmaceutical companies are collaborating to create cost-effective treatment solutions to address this issue and expand access to care for PAD patients.

Underdiagnosis And A Lack Of Awareness

Another impediment to the Peripheral Artery Disease (PAD) business is the disease’s lack of awareness and underdiagnosis. In its early stages, PAD is frequently asymptomatic, and patients may not seek medical attention until the illness has progressed to a more advanced state. Furthermore, many patients and healthcare providers may be unaware of PAD risk factors and symptoms, leading to underdiagnosis and undertreatment. According to a research published in the Journal of the American Medical Association, only 25% of people with PAD are symptomatic, and only 10% are diagnosed.

Lack of awareness and underdiagnosis of PAD can hinder market growth by lowering the number of patients seeking treatment. To address this issue, healthcare providers and patient advocacy organizations are collaborating to raise knowledge of PAD, as well as its risk factors and symptoms. Furthermore, medical device and pharmaceutical companies are investing in the development of diagnostic tools to improve PAD identification and patient access to care.

Growing Demand For Non-Invasive Treatment Options

The growing demand for non-invasive treatment alternatives is one of the prospects in the Peripheral Artery Disease (PAD) industry. Patients with PAD frequently prefer minimally invasive procedures with shorter recovery times and fewer complications. Non-invasive therapy alternatives, like as pharmacological medications, fitness programs, and lifestyle changes, have the potential to transform the PAD treatment landscape. These therapy methods are a safe and effective alternative to surgical procedures, and they can improve patient outcomes dramatically.

In addition, non-invasive therapy alternatives are frequently less expensive than surgical procedures, which can improve access to care for PAD patients. The increased prevalence of PAD and the need for efficient and convenient treatment alternatives are projected to drive up demand for non-invasive treatment solutions. To address this demand and enhance patient outcomes, medical device and pharmaceutical companies are investing in the development of non-invasive therapeutic options. As a result, the market for non-invasive PAD treatment is likely to expand in the coming years.

Medical Technology Advancements

Medical technology advances are another possibility for the Peripheral Artery Disease (PAD) industry. Medical device companies are investing in the development of new equipment and technology that will aid in the diagnosis and treatment of PAD. For example, tremendous progress has been made in the development of drug-eluting stents and bioresorbable stents, which can minimize the risk of restenosis and improve long-term results in PAD patients.

Furthermore, there is significant interest in the application of robotics and artificial intelligence (AI) in the diagnosis and treatment of PAD. These technologies have the potential to increase procedure accuracy and precision, lower the risk of complications, and improve patient outcomes. Furthermore, there is a growing emphasis on the development of wearable gadgets and mobile health applications to assist patients in managing their PAD and monitoring their symptoms. Medical technology improvements are likely to support the growth of the PAD market by improving patient outcomes, lowering healthcare costs, and boosting patient access to care.

Competitive Landscape

Key Players

The global peripheral artery disease market is highly competitive, with the presence of several key players. Some of the major players in the market and their market share are as follows:

  • Bayer AG (Germany)
  • Abbott (US)
  • Boston Scientific Corporation (US)
  • BIOTRONIK (Germany)
  • Cardinal Health (US)
  • Terumo Corporation (Japan)
  • AngioDynamics (US)
  • Koninklijke Philips NV (Netherlands)
  • Cook (US)
  • Medtronic (Ireland)
  • Cardinal Health (US)
  • B. Braun Melsungen AG (Germany)
  • Others

These companies focus on product innovation, expanding their distribution channels, and mergers and acquisitions to stay ahead in the market.

The major players in the global peripheral artery disease market are constantly striving to stay ahead by introducing new products and innovations.

Cardio Flow, Inc., a medical device business and manufacturer of minimally invasive peripheral vascular devices to treat peripheral artery disease (PAD), announced FDA approval for its FreedomFlow Peripheral Guidewire in June 2022.

In January 2022, Cook Medical earned breakthrough device designation from the US Food and Drug Administration (FDA) for a new drug-eluting stent for below the knee (BTK). This new stent is intended to treat people who have limb-threatening chronic ischemia.

In May 2021, Transit Scientific, a development stage medical device company, announced that they have received CE Mark clearance in the European Union for the XO Score Scoring Sheath Platform, which is used to facilitate dilation and apposition of the scoring surface to the stenotic material in the iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries; and for treatment of obstructive lesions. This device aids in the dilatation of stenotic material in the peripheral vasculature, such as infrapopliteal, popliteal, and natural or synthetic arteriovenous dialysis fistulae.

Summary of Key Findings

  • Increased Geriatric Population and Better Insurance and Reimbursement Policies driving market growth
  • Market segmented by treatment type, route of administration, end-users, distribution channel, and region.
  • Hospitals have a market share of approximately 60.4% in 2022.
  • The oral segment is the market’s most popular and in-demand segment.
  • North America is leading market growth; the market is highly competitive with key players including Bayer AG, Abbott, Boston Scientific Corporation and BIOTRONIK.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Future Outlook

  • Medical technology advancements
  • Increasing healthcare spending
  • Increasing Public Awareness of PAD
  • Diagnostic tool technological breakthroughs
  • Geriatric population growth
  • Collaborations and alliances between medical device manufacturers and healthcare providers
  • Novel therapy development
  • There is an increasing need for home healthcare services.

Segmentation

  • By Treatment Type
    • Devices
    • Catheters
    • Drugs
    • Others
  • By Route of Administration
    • Oral
    • Parenteral
    • Others
  • By End Users
    • Hospitals
    • Specialty Clinics
    • Others
  • By Distribution Channel
    • Hospital Pharmacy
    • Retail Pharmacy
    • Others
  • By Region
  • North America
    • USA
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – DataModelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Peripheral Artery Disease Market
2.2. Global Peripheral Artery Disease Market, By Treatment Type
2.3. Global Peripheral Artery Disease Market, By Route of Administration
2.4. Global Peripheral Artery Disease Market, By End-Users
2.5. Global Peripheral Artery Disease Market, By Distribution Channel
2.6. Global Peripheral Artery Disease Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Peripheral Artery Disease Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Treatment Type
3.5.2. Route of Administration
3.5.3. End-Users
3.5.4. Distribution Channel
3.5.5. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Treatment Type Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Treatment Type Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Peripheral Artery Disease Market, By Treatment Type
7.1. Global Peripheral Artery Disease Market Overview, By Treatment Type
7.1.1. Global Peripheral Artery Disease Market Revenue Share, By Treatment Type, 2022 Vs 2030 (in %)
7.2. Devices
7.2.1. Global Peripheral Artery Disease Market, By Region, 2017-2030 (US$ Bn)
7.3. Catheters
7.3.1. Global Peripheral Artery Disease Market, By Region, 2017-2030 (US$ Bn)
7.4. Drugs
7.4.1. Global Peripheral Artery Disease Market, By Region, 2017-2030 (US$ Bn)

8. Global Peripheral Artery Disease Market, By Route of Administration
8.1. Global Peripheral Artery Disease Market Overview, By Route of Administration
8.1.1. Global Peripheral Artery Disease Market, By Route of Administration, 2022 vs. 2030 (in%)
8.2. Oral
8.2.1. Global Peripheral Artery Disease Market, By Region, 2017-2030 (US$ Bn)
8.3. Parenteral
8.3.1. Global Peripheral Artery Disease Market, By Region, 2017-2030 (US$ Bn)
8.4. Others
8.4.1. Global Peripheral Artery Disease Market, By Region, 2017-2030 (US$ Bn)

9. Global Peripheral Artery Disease Market, By End-Users, 2017-2030(US$ Bn)
9.1. Global Peripheral Artery Disease Market Overview, By End-Users
9.1.1. Global Peripheral Artery Disease Market, By End-Users, 2022 vs 2030 (in%)
9.2. Hospital
9.2.1. Global Peripheral Artery Disease Market, By Region, 2017-2030 (US$ Bn)
9.3. Specialty Clinic
9.3.1. Global Peripheral Artery Disease Market, By Region, 2017-2030 (US$ Bn)
9.4. Others
9.4.1. Global Peripheral Artery Disease Market, By Region, 2017-2030 (US$ Bn)

10. Global Peripheral Artery Disease Market, By Distribution Channel, 2017-2030(US$ Bn)
10.1 Global Peripheral Artery Disease Market Overview, By Distribution Channel
10.1.1. Global Peripheral Artery Disease Market, By Distribution Channel, 2022 vs 2030 (in %)
10.2. Hospital Pharmacy
10.2.1. Global Peripheral Artery Disease Market, By Region, 2017-2030 (US$ Bn)
10.3. Retail Pharmacy
10.3.1. Global Peripheral Artery Disease Market, By Region, 2017-2030 (US$ Bn)
10.4. Others
10.4.1. Global Peripheral Artery Disease Market, By Region, 2017-2030 (US$ Bn)

11. Global Peripheral Artery Disease Market, By Region
11.1. Global Peripheral Artery Disease Market Overview, by Region
11.1.1. Global Peripheral Artery Disease Market, By Region, 2022 vs 2030 (in%)
11.2. Treatment Type
11.2.1. Global Peripheral Artery Disease Market, By Treatment Type, 2017-2030 (US$ Bn)
11.3. Route of Administration
11.3.1. Global Peripheral Artery Disease Market, By Route of Administration, 2017-2030 (US$ Bn)
11.4. End-Users
11.4.1. Global Peripheral Artery Disease Market, By End-Users, 2017-2030 (US$ Bn)
11.5. Distribution Channel
11.5.1. Global Peripheral Artery Disease Market, By Distribution Channel, 2017-2030 (US$ Bn)

12. North America Peripheral Artery Disease Market Analysis
12.1. North America Peripheral Artery Disease Market, By Treatment Type, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. North America Peripheral Artery Disease Market, By Route of Administration, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. North America Peripheral Artery Disease Market, By End-Users, 2017-2030(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. North America Peripheral Artery Disease Market, By Distribution Channel, 2017-2030(US$ Bn)
12.4.1. Overview
12.4.2. SRC Analysis
12.5. North America Peripheral Artery Disease Market, by Country, 2017-2030(US$ Bn)
12.5.1. North America Peripheral Artery Disease Market, by Country, 2022 Vs 2030 (in %)
12.5.2. U.S.
12.5.2.1. U.S. Peripheral Artery Disease Market Estimates and Forecast, 2017-2030(US$ Bn)
12.5.2.2. U.S. Peripheral Artery Disease, By Treatment Type, 2017-2030(US$ Bn)
12.5.2.3. U.S. Peripheral Artery Disease, By Route of Administration, 2017-2030(US$ Bn)
12.5.2.4. U.S. Peripheral Artery Disease, By End-Users, 2017-2030 (US$ Bn)
12.5.2.5. U.S. Peripheral Artery Disease, By Distribution Channel, 2017-2030 (US$ Bn)
12.5.3. Canada
12.5.3.1. Canada Peripheral Artery Disease Market Estimates and Forecast, 2017-2030(US$ Bn)
12.5.3.2. Canada Peripheral Artery Disease, By Treatment Type, 2017-2030(US$ Bn)
12.5.3.3. Canada Peripheral Artery Disease, By Route of Administration, 2017-2030(US$ Bn)
12.5.3.4. Canada Peripheral Artery Disease, By End-Users, 2017-2030 (US$ Bn)
12.5.3.5. Canada Peripheral Artery Disease, By Distribution Channel, 2017-2030 (US$ Bn)
12.5.4. Mexico
12.5.4.1. Mexico Peripheral Artery Disease Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.5.4.2. Mexico Peripheral Artery Disease, By Treatment Type, 2017-2030 (US$ Bn)
12.5.4.3. Mexico Peripheral Artery Disease, By Route of Administration, 2017-2030 (US$ Bn)
12.5.4.4. Mexico Peripheral Artery Disease, By End-Users, 2017-2030 (US$ Bn)
12.5.4.5. Mexico Peripheral Artery Disease, By Distribution Channel, 2017-2030 (US$ Bn)

13. Europe Peripheral Artery Disease Market Analysis
13.1. Europe Peripheral Artery Disease Market, By Treatment Type, 2017-2030(US$ Bn)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Europe Peripheral Artery Disease Market, By Route of Administration, 2017-2030(US$ Bn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. Europe Peripheral Artery Disease Market, By End-Users, 2017-2030(US$ Bn)
13.3.1. Overview
13.3.2. SRC Analysis
13.4. Europe Peripheral Artery Disease Market, By Distribution Channel, 2017-2030(US$ Bn)
13.4.1. Overview
13.4.2. SRC Analysis
13.5. Europe Peripheral Artery Disease Market, by Country, 2017-2030(US$ Bn)
13.5.1. EuropePeripheral Artery Disease Market, by Country, 2022 Vs 2030 (in%)
13.5.2. Germany
13.5.2.1. Germany Peripheral Artery Disease Market Estimates and Forecast, 2017-2030(US$ Bn)
13.5.2.2. Germany Peripheral Artery Disease, By Treatment Type, 2017-2030(US$ Bn)
13.5.2.3. Germany Peripheral Artery Disease, By Route of Administration, 2017-2030(US$ Bn)
13.5.3. Germany Peripheral Artery Disease, By End-Users, 2017-2030 (US$ Bn)
13.5.4. Germany Peripheral Artery Disease, By Distribution Channel, 2017-2030 (US$ Bn)
13.5.5. France
13.5.5.1. France Peripheral Artery Disease Market Estimates and Forecast, 2017-2030(US$ Bn)
13.5.5.2. France Peripheral Artery Disease, By Treatment Type, 2017-2030(US$ Bn)
13.5.5.3. France Peripheral Artery Disease, By Route of Administration, 2017-2030(US$ Bn)
13.5.5.4. France Peripheral Artery Disease, By End-Users, 2017-2030 (US$ Bn)
13.5.5.5. France Peripheral Artery Disease, By Distribution Channel, 2017-2030 (US$ Bn)
13.5.6. UK
13.5.6.1. UK Peripheral Artery Disease Market Estimates and Forecast, 2017-2030(US$ Bn)
13.5.6.2. UK Peripheral Artery Disease, By Treatment Type, 2017-2030(US$ Bn)
13.5.6.3. UK Peripheral Artery Disease, By Route of Administration, 2017-2030(US$ Bn)
13.5.6.4. UK Peripheral Artery Disease, By End-Users, 2017-2030 (US$ Bn)
13.5.6.5. UK Peripheral Artery Disease, By Distribution Channel, 2017-2030 (US$ Bn)
13.5.7. Italy
13.5.7.1. Italy Peripheral Artery Disease Market Estimates and Forecast, 2017-2030(US$ Bn)
13.5.7.2. Italy Peripheral Artery Disease, By Treatment Type, 2017-2030(US$ Bn)
13.5.7.3. Italy Peripheral Artery Disease, By Route of Administration, 2017-2030(US$ Bn)
13.5.7.4. Italy Peripheral Artery Disease, By End-Users, 2017-2030 (US$ Bn)
13.5.7.5. Italy Peripheral Artery Disease, By Distribution Channel, 2017-2030 (US$ Bn)
13.5.8. Spain
13.5.8.1. Spain Peripheral Artery Disease Market Estimates and Forecast, 2017-2030(US$ Bn)
13.5.8.2. Spain Peripheral Artery Disease, By Treatment Type, 2017-2030(US$ Bn)
13.5.8.3. Spain Peripheral Artery Disease, By Route of Administration, 2017-2030(US$ Bn)
13.5.8.4. Spain Peripheral Artery Disease, By End-Users, 2017-2030 (US$ Bn)
13.5.8.5. Spain Peripheral Artery Disease, By Distribution Channel, 2017-2030 (US$ Bn)
13.5.9. Rest of Europe
13.5.9.1. Rest of Europe Peripheral Artery Disease Market Estimates and Forecast, 2017-2030(US$ Bn)
13.5.9.2. Rest of Europe Peripheral Artery Disease, By Treatment Type, 2017-2030(US$ Bn)
13.5.9.3. Rest of Europe Peripheral Artery Disease, By Route of Administration, 2017-2030(US$ Bn)
13.5.9.4. Rest of Europe Peripheral Artery Disease, By End-Users, 2017-2030 (US$ Bn)
13.5.9.5. Rest of Europe Peripheral Artery Disease, By Distribution Channel, 2017-2030 (US$ Bn)

14. Asia Pacific Peripheral Artery Disease Market Analysis
14.1. Asia Pacific Peripheral Artery Disease Market, By Treatment Type, 2017-2030(US$ Bn)
14.1.1. Overview
14.1.2. SRC Analysis
14.2. Asia Pacific Peripheral Artery Disease Market, By Route of Administration, 2017-2030(US$ Bn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Asia Pacific Peripheral Artery Disease Market, By End-Users, 2017-2030(US$ Bn)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. Asia Pacific Peripheral Artery Disease Market, By Distribution Channel, 2017-2030(US$ Bn)
14.4.1. Overview
14.4.2. SRC Analysis
14.5. Asia Pacific Peripheral Artery Disease Market, by Country, 2017-2030(US$ Bn)
14.5.1. Asia PacificPeripheral Artery Disease Market, by Country, 2022 Vs 2030 (in%)
14.5.2. China
14.5.2.1. China Peripheral Artery Disease Market Estimates and Forecast, 2017-2030(US$ Bn)
14.5.2.2. China Peripheral Artery Disease, By Treatment Type, 2017-2030(US$ Bn)
14.5.2.3. China Peripheral Artery Disease, By Route of Administration, 2017-2030(US$ Bn)
14.5.2.4. China Peripheral Artery Disease, By End-Users, 2017-2030 (US$ Bn)
14.5.2.5. China Peripheral Artery Disease, By Distribution Channel, 2017-2030 (US$ Bn)
14.5.3. Japan
14.5.3.1. Japan Peripheral Artery Disease Market Estimates and Forecast, 2017-2030(US$ Bn)
14.5.3.2. Japan Peripheral Artery Disease, By Treatment Type, 2017-2030(US$ Bn)
14.5.3.3. Japan Peripheral Artery Disease, By Route of Administration, 2017-2030(US$ Bn)
14.5.3.4. Japan Peripheral Artery Disease, By End-Users, 2017-2030 (US$ Bn)
14.5.3.5. Japan Peripheral Artery Disease, By Distribution Channel, 2017-2030 (US$ Bn)
14.5.4. India
14.5.4.1. India Peripheral Artery Disease Market Estimates and Forecast, 2017-2030(US$ Bn)
14.5.4.2. India Peripheral Artery Disease, By Treatment Type, 2017-2030(US$ Bn)
14.5.4.3. India Peripheral Artery Disease, By Route of Administration, 2017-2030(US$ Bn)
14.5.4.4. India Peripheral Artery Disease, By End-Users, 2017-2030 (US$ Bn)
14.5.4.5. India Peripheral Artery Disease, By Distribution Channel, 2017-2030 (US$ Bn)
14.5.5. South Korea
14.5.5.1. South Korea Peripheral Artery Disease Market Estimates and Forecast, 2017-2030(US$ Bn)
14.5.5.2. South Korea Peripheral Artery Disease, By Treatment Type, 2017-2030(US$ Bn)
14.5.5.3. South Korea Peripheral Artery Disease, By Route of Administration, 2017-2030(US$ Bn)
14.5.5.4. South Korea Peripheral Artery Disease, By End-Users, 2017-2030 (US$ Bn)
14.5.5.5. South Korea Peripheral Artery Disease, By Distribution Channel, 2017-2030 (US$ Bn)
14.5.6. South-East Asia
14.5.6.1. South-East Asia Peripheral Artery Disease Market Estimates and Forecast, 2017-2030(US$ Bn)
14.5.6.2. South-East Asia Peripheral Artery Disease, By Treatment Type, 2017-2030(US$ Bn)
14.5.6.3. South-East Asia Peripheral Artery Disease, By Route of Administration, 2017-2030(US$ Bn)
14.5.6.4. South-East Asia Peripheral Artery Disease, By End-Users, 2017-2030 (US$ Bn)
14.5.6.5. South-East Asia Peripheral Artery Disease, By Distribution Channel, 2017-2030 (US$ Bn)
14.5.7. Rest of Asia Pacific
14.5.7.1. Rest of Asia Pacific Peripheral Artery Disease Market Estimates and Forecast, 2017-2030(US$ Bn)
14.5.7.2. Rest of Asia Pacific Peripheral Artery Disease, By Treatment Type, 2017-2030(US$ Bn)
14.5.7.3. Rest of Asia Pacific Peripheral Artery Disease, By Route of Administration, 2017-2030(US$ Bn)
14.5.7.4. Rest of Asia Pacific Peripheral Artery Disease, By End-Users, 2017-2030 (US$ Bn)
14.5.7.5. Rest of Asia Pacific Peripheral Artery Disease, By Distribution Channel, 2017-2030 (US$ Bn)

15. Latin America Peripheral Artery Disease Market Analysis
15.1. Latin America Peripheral Artery Disease Market, By Treatment Type, 2017-2030(US$ Bn)
15.1.1. Overview
15.1.2. SRC Analysis
15.2. Latin America Peripheral Artery Disease Market, By Route of Administration, 2017-2030(US$ Bn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Latin America Peripheral Artery Disease Market, By End-Users, 2017-2030(US$ Bn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Latin America Peripheral Artery Disease Market, By Distribution Channel, 2017-2030(US$ Bn)
15.4.1. Overview
15.4.2. SRC Analysis
15.5. Latin America Peripheral Artery Disease Market, by Country, 2017-2030(US$ Bn)
15.5.1. LatinAmerica Peripheral Artery Disease Market, by Country, 2022 Vs 2030 (in%)
15.5.2. Brazil
15.5.2.1. Brazil Peripheral Artery Disease Market Estimates and Forecast, 2017-2030(US$ Bn)
15.5.2.2. Brazil Peripheral Artery Disease, By Treatment Type, 2017-2030(US$ Bn)
15.5.2.3. Brazil Peripheral Artery Disease, By Route of Administration, 2017-2030(US$ Bn)
15.5.2.4. Brazil Peripheral Artery Disease, By End-Users, 2017-2030 (US$ Bn)
15.5.2.5. Brazil Peripheral Artery Disease, By Distribution Channel, 2017-2030 (US$ Bn)
15.5.3. Argentina
15.5.3.1. Argentina Peripheral Artery Disease Market Estimates and Forecast, 2017-2030(US$ Bn)
15.5.3.2. Argentina Peripheral Artery Disease, By Treatment Type, 2017-2030(US$ Bn)
15.5.3.3. Argentina Peripheral Artery Disease, By Route of Administration, 2017-2030(US$ Bn)
15.5.3.4. Argentina Peripheral Artery Disease, By End-Users, 2017-2030 (US$ Bn)
15.5.3.5. Argentina Peripheral Artery Disease, By Distribution Channel, 2017-2030 (US$ Bn)
15.5.4. Rest of Latin America
15.5.4.1. Rest of Latin America Peripheral Artery Disease Market Estimates and Forecast, 2017-2030(US$ Bn)
15.5.4.2. Rest of Latin America Peripheral Artery Disease, By Treatment Type, 2017-2030(US$ Bn)
15.5.4.3. Rest of Latin America Peripheral Artery Disease, By Route of Administration, 2017-2030(US$ Bn)
15.5.4.4. Rest of Latin America Peripheral Artery Disease, By End-Users, 2017-2030 (US$ Bn)
15.5.4.5. Rest of Latin America Peripheral Artery Disease, By Distribution Channel, 2017-2030 (US$ Bn)

16. Middle East and Africa Peripheral Artery Disease Market Analysis
16.1. Middle East and Africa Peripheral Artery Disease Market, By Treatment Type, 2017-2030(US$ Bn)
16.1.1. Overview
16.1.2. SRC Analysis
16.2. Middle East and Africa Peripheral Artery Disease Market, By Route of Administration, 2017-2030(US$ Bn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. Middle East and Africa Peripheral Artery Disease Market, By End-Users, 2017-2030(US$ Bn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. Middle East and Africa Peripheral Artery Disease Market, By Distribution Channel, 2017-2030(US$ Bn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. Middle East and Africa Peripheral Artery Disease Market, by Country, 2017-2030(US$ Bn)
16.5.1. Middle East and AfricaPeripheral Artery Disease Market, by Country, 2022 Vs 2030 (in%)
16.5.2. GCC Countries
16.5.2.1. GCC Countries Peripheral Artery Disease Market Estimates and Forecast, 2017-2030(US$ Bn)
16.5.2.2. GCC Countries Peripheral Artery Disease, By Treatment Type, 2017-2030(US$ Bn)
16.5.2.3. GCC Countries Peripheral Artery Disease, By Route of Administration, 2017-2030(US$ Bn)
16.5.2.4. GCC Countries Peripheral Artery Disease, By End-Users, 2017-2030 (US$ Bn)
16.5.2.5. GCC Countries Peripheral Artery Disease, By Distribution Channel, 2017-2030 (US$ Bn)
16.5.3. South Africa
16.5.3.1. South Africa Peripheral Artery Disease Market Estimates and Forecast, 2017-2030(US$ Bn)
16.5.3.2. South Africa Peripheral Artery Disease, By Treatment Type, 2017-2030(US$ Bn)
16.5.3.3. South Africa Peripheral Artery Disease, By Route of Administration, 2017-2030(US$ Bn)
16.5.3.4. South Africa Peripheral Artery Disease, By End-Users, 2017-2030 (US$ Bn)
16.5.3.5. South Africa Peripheral Artery Disease, By Distribution Channel, 2017-2030 (US$ Bn)
16.5.4. Rest of Middle East and Africa
16.5.4.1. Rest of Middle East and Africa Peripheral Artery Disease Market Estimates and Forecast, 2017-2030(US$ Bn)
16.5.4.2. Rest of Middle East and Africa Peripheral Artery Disease, By Treatment Type, 2017-2030(US$ Bn)
16.5.4.3. Rest of Middle East and Africa Peripheral Artery Disease, By Route of Administration, 2017-2030(US$ Bn)
16.5.4.4. Rest of Middle East and Africa Peripheral Artery Disease, By End-Users, 2017-2030 (US$ Bn)
16.5.4.5. Rest of Middle East and Africa Peripheral Artery Disease, By Distribution Channel, 2017-2030 (US$ Bn)

17. Company Profiles
17.1. Bayer AG
17.1.1. Company Overview
17.1.2. Treatment Types/Services Portfolio
17.1.3. Geographical Presence
17.1.4. Financial Summary
17.1.4.1. Market Revenue and Net Profit (2019-2022)
17.1.4.2. Business Segment Revenue Analysis
17.1.4.3. Geographical Revenue Analysis
17.2. Abbott (US)
17.3. Boston Scientific Corporation (US)
17.4. BIOTRONIK (Germany)
17.5. Cardinal Health (US)
17.6. Terumo Corporation (Japan)
17.7. AngioDynamics (US)
17.8. Koninklijke Philips NV (Netherlands)
17.9. Cook (US)
17.10. Medtronic (Ireland)
17.11. Cardinal Health (US)
17.12. B. Braun Melsungen AG (Germany)

List of Figures
FIG. 1 Global Peripheral Artery Disease Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Peripheral Artery Disease Market Segmentation
FIG. 4 Global Peripheral Artery Disease Market, By Treatment Type, 2022(US$ Bn)
FIG. 5 Global Peripheral Artery Disease Market, By Route of Administration, 2022(US$ Bn)
FIG. 6 Global Peripheral Artery Disease Market, By End-Users, 2022 (US$ Bn)
FIG. 7 Global Peripheral Artery Disease Market, By Distribution Channel, 2022 (US$ Bn)
FIG. 8 Global Peripheral Artery Disease Market, by Geography, 2022(US$ Bn)
FIG. 9 Attractive Investment Proposition, By Treatment Type, 2022
FIG. 10 Attractive Investment Proposition, By Route of Administration, 2022
FIG. 11 Attractive Investment Proposition, By End-Users, 2022
FIG. 12 Attractive Investment Proposition, By Distribution Channel, 2022
FIG. 13 Attractive Investment Proposition, by Geography, 2022
FIG. 14 Global Market Share Analysis of Key Peripheral Artery Disease Market Manufacturers, 2022
FIG. 15 Global Market Positioning of Key Peripheral Artery Disease Market Manufacturers, 2022
FIG. 16 Global Peripheral Artery Disease Market Value Contribution, By Treatment Type, 2022&2030 (Value %)
FIG. 17 Global Peripheral Artery DiseaseMarket, by Devices, Value, 2017-2030(US$ Bn)
FIG. 18 Global Peripheral Artery DiseaseMarket, by Catheters, Value, 2017-2030(US$ Bn)
FIG. 19 Global Peripheral Artery Disease Market, by Drugs, Value, 2017-2030 (US$ Bn)
FIG. 20 Global Peripheral Artery Disease Market, by Others, Value, 2017-2030 (US$ Bn)
FIG. 21 Global Peripheral Artery Disease Market Value Contribution, By Route of Administration, 2022&2030 (Value %)
FIG. 22 Global Peripheral Artery DiseaseMarket, by Oral, Value, 2017-2030(US$ Bn)
FIG. 23 Global Peripheral Artery DiseaseMarket, by Parenteral, 2017-2030(US$ Bn)
FIG. 24 Global Peripheral Artery Disease Market, by others, 2017-2030(US$ Bn)
FIG. 25 Global Peripheral Artery Disease Market Value Contribution, By End-Users, 2022 & 2030 (Value %)
FIG. 26 Global Peripheral Artery Disease Market, by Hospital, Value, 2017-2030 (US$ Bn)
FIG. 27 Global Peripheral Artery Disease Market, by Specialty Clinic, 2017-2030 (US$ Bn)
FIG. 28 Global Peripheral Artery Disease Market, by Others, 2017-2030 (US$ Bn)
FIG. 29 Global Peripheral Artery Disease Market Value Contribution, By Distribution Channel, 2022 & 2030 (Value %)
FIG. 30 Global Peripheral Artery Disease Market, by Hospital Pharmacy, Value, 2017-2030 (US$ Bn)
FIG. 31 Global Peripheral Artery Disease Market, by Retail Pharmacy, Value, 2017-2030 (US$ Bn)
FIG. 32 Global Peripheral Artery Disease Market, by others, Value, 2017-2030 (US$ Bn)
FIG. 33 North America Peripheral Artery Disease Market, 2017-2030 (US$ Bn)
FIG. 34 U.S. Peripheral Artery Disease Market, 2017-2030(US$ Bn)
FIG. 35 Canada Peripheral Artery Disease Market, 2017-2030(US$ Bn)
FIG. 36 Europe Peripheral Artery Disease Market, 2017-2030 (US$ Bn)
FIG. 37 Germany Peripheral Artery Disease Market, 2017-2030(US$ Bn)
FIG. 38 France Peripheral Artery Disease Market, 2017-2030(US$ Bn)
FIG. 39 U.K. Peripheral Artery Disease Market, 2017-2030(US$ Bn)
FIG. 40 Italy Peripheral Artery Disease Market, 2017-2030(US$ Bn)
FIG. 41 Spain Peripheral Artery Disease Market, 2017-2030(US$ Bn)
FIG. 42 Rest of Europe Peripheral Artery Disease Market, 2017-2030(US$ Bn)
FIG. 43 Asia Pacific Peripheral Artery Disease Market, 2017-2030 (US$ Bn)
FIG. 44 China Peripheral Artery Disease Market, 2017-2030(US$ Bn)
FIG. 45 Japan Peripheral Artery Disease Market, 2017-2030(US$ Bn)
FIG. 46 India Peripheral Artery Disease Market, 2017-2030(US$ Bn)
FIG. 47 South Korea Peripheral Artery Disease Market, 2017-2030(US$ Bn)
FIG. 48 South-East Asia Peripheral Artery Disease Market, 2017-2030(US$ Bn)
FIG. 49 Rest of Asia Pacific Peripheral Artery Disease Market, 2017-2030(US$ Bn)
FIG. 50 Latin America Peripheral Artery Disease Market, 2017-2030(US$ Bn)
FIG. 51 Brazil Peripheral Artery Disease Market, 2017-2030(US$ Bn)
FIG. 52 Mexico Peripheral Artery Disease Market, 2017-2030(US$ Bn)
FIG. 53 Rest of Latin America Peripheral Artery Disease Market, 2017-2030(US$ Bn)
FIG. 54 Middle East & Africa Peripheral Artery Disease Market, 2017-2030(US$ Bn)
FIG. 55 GCC Countries Peripheral Artery Disease Market, 2017-2030(US$ Bn)
FIG. 56 South Africa Peripheral Artery Disease Market, 2017-2030(US$ Bn)
FIG. 57 Rest of Middle East and Africa Peripheral Artery Disease Market, 2017-2030(US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Peripheral Artery DiseaseMarket
TABLE 2 Global Peripheral Artery Disease Market: Market Drivers Impact Analysis
TABLE 3 Global Peripheral Artery Disease Market: Market Restraints Impact Analysis
TABLE 4 Global Peripheral Artery Disease Market, by Competitive Benchmarking,2022
TABLE 5 Global Peripheral Artery Disease Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Peripheral Artery Disease Market, by Key Strategies Analysis, 2022
TABLE 7 Global Peripheral Artery Disease Market, by Devices, By Region, 2017-2022(US$ Bn)
TABLE 8 Global Peripheral Artery Disease Market, by Catheters, By Region, 2023-2030(US$ Bn)
TABLE 9 Global Peripheral Artery Disease Market, by Drugs, By Region, 2023-2030(US$ Bn)
TABLE 10 Global Peripheral Artery Disease Market, by Others, By Region, 2023-2030(US$ Bn)
TABLE 11 Global Peripheral Artery Disease Market, by Oral, By Region, 2017-2022(US$ Bn)
TABLE 12 Global Peripheral Artery Disease Market, by Oral, By Region, 2023-2030(US$ Bn)
TABLE 13 Global Peripheral Artery Disease Market, by Parenteral, By Region, 2017-2022(US$ Bn)
TABLE 14 Global Peripheral Artery Disease Market, by Parenteral, By Region, 2023-2030(US$ Bn)
TABLE 15 Global Peripheral Artery Disease Market, by Others, By Region, 2017-2022(US$ Bn)
TABLE 16 Global Peripheral Artery Disease Market, by Others, By Region, 2023-2030(US$ Bn)
TABLE 17 Global Peripheral Artery Disease Market, by Hospital, By Region, 2017-2022(US$ Bn)
TABLE 18 Global Peripheral Artery Disease Market, by Hospital, By Region, 2023-2030(US$ Bn)
TABLE 19 Global Peripheral Artery Disease Market, by Specialty Clinic, By Region, 2017-2022(US$ Bn)
TABLE 20 Global Peripheral Artery Disease Market, by Specialty Clinic, By Region, 2023-2030(US$ Bn)
TABLE 21 Global Peripheral Artery Disease Market, by Others, By Region, 2017-2022(US$ Bn)
TABLE 22 Global Peripheral Artery Disease Market, by Others, By Region, 2023-2030(US$ Bn)
TABLE 23 Global Peripheral Artery Disease Market, by Hospital Pharmacy, By Region, 2023-2030(US$ Bn)
TABLE 24 Global Peripheral Artery Disease Market, by Hospital Pharmacy, By Region, 2017-2022(US$ Bn)
TABLE 25 Global Peripheral Artery Disease Market, by Retail Pharmacy, By Region, 2023-2030(US$ Bn)
TABLE 26 Global Peripheral Artery Disease Market, by Retail Pharmacy, By Region, 2017-2022(US$ Bn)
TABLE 27 Global Peripheral Artery Disease Market, by others, By Region, 2023-2030(US$ Bn)
TABLE 28 Global Peripheral Artery Disease Market, by Others, By Region, 2017-2022(US$ Bn)
TABLE 29 Global Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 30 Global Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 31 Global Peripheral Artery Disease Market, By Route of Administration, 2017-2022(US$ Bn)
TABLE 32 Global Peripheral Artery Disease Market, By Route of Administration, 2023-2030(US$ Bn)
TABLE 33 Global Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 34 Global Peripheral Artery Disease Market, By End-Users, 2023-2030 (US$ Bn)
TABLE 35 Global Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 36 Global Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 37 Global Peripheral Artery Disease Market, by Region, 2017-2022(US$ Bn)
TABLE 38 Global Peripheral Artery Disease Market, by Region, 2023-2030(US$ Bn)
TABLE 39 North America Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 40 North America Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 41 North America Peripheral Artery Disease Market, By Route of Administration, 2017-2022(US$ Bn)
TABLE 42 North America Peripheral Artery Disease Market, By Route of Administration, 2023-2030(US$ Bn)
TABLE 43 North America Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 44 North America Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 45 North America Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 46 North America Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 47 North America Peripheral Artery Disease Market, by Country, 2017-2022(US$ Bn)
TABLE 48 North America Peripheral Artery Disease Market, by Country, 2023-2030(US$ Bn)
TABLE 49 United States Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 50 United States Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 51 United States Peripheral Artery Disease Market, By Route of Administration, 2017-2022(US$ Bn)
TABLE 52 United States Peripheral Artery Disease Market, By Route of Administration, 2023-2030(US$ Bn)
TABLE 53 United States Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 54 United States Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 55 United States Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 56 United States Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 57 Canada Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 58 Canada Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 59 Canada Peripheral Artery Disease Market, by Route of Administrations, 2017-2022(US$ Bn)
TABLE 60 Canada Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 61 Canada Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 62 Canada Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 63 Canada Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 64 Canada Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 65 Mexico Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 66 Mexico Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 67 Mexico Peripheral Artery Disease Market, by Route of Administration, 2017-2022(US$ Bn)
TABLE 68 Mexico Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 69 Mexico Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 70 Mexico Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 71 Mexico Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 72 Mexico Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 73 Europe Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 74 Europe Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 75 Europe Peripheral Artery Disease Market, by Route of Administration, 2017-2022(US$ Bn)
TABLE 76 Europe Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 77 Europe Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 78 Europe Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 79 Europe Peripheral Artery Disease Market, by Distribution Channel, 2017-2022(US$ Bn)
TABLE 80 Europe Peripheral Artery Disease Market, by Distribution Channel, 2023-2030(US$ Bn)
TABLE 81 Germany Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 82 Germany Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 83 Germany Peripheral Artery Disease Market, by Route of Administration, 2017-2022(US$ Bn)
TABLE 84 Germany Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 85 Germany Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 86 Germany Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 87 Germany Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 88 Germany Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 89 France Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 90 France Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 91 France Peripheral Artery Disease Market, by Route of Administration, 2017-2022(US$ Bn)
TABLE 92 France Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 93 France Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 94 France Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 95 France Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 96 France Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 97 United Kingdom Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 98 United Kingdom Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 99 United Kingdom Peripheral Artery Disease Market, by Route of Administration, 2017-2022(US$ Bn)
TABLE 100 United Kingdom Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 101 United Kingdom Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 102 United Kingdom Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 103 United Kingdom Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 104 United Kingdom Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 105 Italy Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 106 Italy Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 107 Italy Peripheral Artery Disease Market, by Route of Administration, 2017-2022(US$ Bn)
TABLE 108 Italy Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 109 Italy Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 110 Italy Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 111 Italy Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 112 Italy Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 113 Spain Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 114 Spain Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 115 Spain Peripheral Artery Disease Market, by Route of Administration, 2017-2022(US$ Bn)
TABLE 116 Spain Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 117 Spain Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 118 Spain Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 119 Spain Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 120 Spain Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 121 Rest of Europe Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 122 Rest of Europe Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 123 Rest of Europe Peripheral Artery Disease Market, by Route of Administration, 2017-2022(US$ Bn)
TABLE 124 Rest of Europe Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 125 Rest of Europe Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 126 Rest of Europe Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 127 Rest of Europe Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 128 Rest of Europe Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 129
TABLE 130 Asia Pacific Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 131 Asia Pacific Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 132 Asia Pacific Peripheral Artery Disease Market, by Route of Administration, 2017-2022(US$ Bn)
TABLE 133 Asia Pacific Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 134 Asia Pacific Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 135 Asia Pacific Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 136 Asia Pacific Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 137 Asia Pacific Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 138 China Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 139 China Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 140 China Peripheral Artery Disease Market, by Route of Administration, 2017-2022(US$ Bn)
TABLE 141 China Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 142 China Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 143 China Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 144 China Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 145 China Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 146 Japan Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 147 Japan Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 148 Japan Peripheral Artery Disease Market, by Route of Administration, 2017-2022(US$ Bn)
TABLE 149 Japan Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 150 Japan Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 151 Japan Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 152 Japan Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 153 Japan Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 154 India Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 155 India Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 156 India Peripheral Artery Disease Market, by Route of Administration, 2017-2022(US$ Bn)
TABLE 157 India Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 158 India Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 159 India Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 160 India Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 161 India Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 162 South Korea Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 163 South Korea Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 164 South Korea Peripheral Artery Disease Market, by Route of Administration, 2017-2022(US$ Bn)
TABLE 165 South Korea Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 166 South Korea Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 167 South Korea Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 168 South Korea Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 169 South Korea Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 170 South-East Asia Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 171 South-East Asia Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 172 South-East Asia Peripheral Artery Disease Market, by Route of Administration, 2017-2022(US$ Bn)
TABLE 173 South-East Asia Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 174 South-East Asia Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 175 South-East Asia Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 176 South-East Asia Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 177 South-East Asia Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 178 Rest of Asia Pacific Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 179 Rest of Asia Pacific Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 180 Rest of Asia Pacific Peripheral Artery Disease Market, by Route of Administration, 2017-2022(US$ Bn)
TABLE 181 Rest of Asia Pacific Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 182 Rest of Asia Pacific Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 183 Rest of Asia Pacific Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 184 Rest of Asia Pacific Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 185 Rest of Asia Pacific Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 186 Latin America Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 187 Latin America Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 188 Latin America Peripheral Artery Disease Market, by Route of Administration, 2017-2022(US$ Bn)
TABLE 189 Latin America Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 190 Latin America Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 191 Latin America Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 192 Latin America Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 193 Latin America Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 194 Brazil Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 195 Brazil Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 196 Brazil Peripheral Artery Disease Market, by Route of Administration, 2017-2022(US$ Bn)
TABLE 197 Brazil Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 198 Brazil Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 199 Brazil Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 200 Brazil Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 201 Brazil Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 202 Argentina Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 203 Argentina Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 204 Argentina Peripheral Artery Disease Market, by Route of Administration, 2017-2022(US$ Bn)
TABLE 205 Argentina Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 206 Argentina Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 207 Argentina Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 208 Argentina Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 209 Argentina Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 210 Rest of Latin America Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 211 Rest of Latin America Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 212 Rest of Latin America Peripheral Artery Disease Market, by Route of Administration, 2017-2022(US$ Bn)
TABLE 213 Rest of Latin America Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 214 Rest of Latin America Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 215 Rest of Latin America Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 216 Rest of Latin America Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 217 Rest of Latin America Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 218 Middle East and Africa Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 219 Middle East and Africa Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 220 Middle East and Africa Peripheral Artery Disease Market, by Route of Administration, 2017-2022(US$ Bn)
TABLE 221 Middle East and Africa Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 222 Middle East and Africa Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 223 Middle East and Africa Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 224 Middle East and Africa Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 225 Middle East and Africa Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 226 GCC Countries Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 227 GCC Countries Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 228 GCC Countries Peripheral Artery Disease Market, by Route of Administration, 2017-2022(US$ Bn)
TABLE 229 GCC Countries Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 230 GCC Countries Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 231 GCC Countries Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 232 GCC Countries Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 233 GCC Countries Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 234 South Africa Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 235 South Africa Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 236 South Africa Peripheral Artery Disease Market, by Route of Administration, 2017-2022(US$ Bn)
TABLE 237 South Africa Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 238 South Africa Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 239 South Africa Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 240 South Africa Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 241 South Africa Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)
TABLE 242 Rest of Middle East and Africa Peripheral Artery Disease Market, By Treatment Type, 2017-2022(US$ Bn)
TABLE 243 Rest of Middle East and Africa Peripheral Artery Disease Market, By Treatment Type, 2023-2030(US$ Bn)
TABLE 244 Rest of Middle East and Africa Peripheral Artery Disease Market, by Route of Administration, 2017-2022(US$ Bn)
TABLE 245 Rest of Middle East and Africa Peripheral Artery Disease Market, by Route of Administration, 2023-2030(US$ Bn)
TABLE 246 Rest of Middle East and Africa Peripheral Artery Disease Market, By End-Users, 2017-2022(US$ Bn)
TABLE 247 Rest of Middle East and Africa Peripheral Artery Disease Market, By End-Users, 2023-2030(US$ Bn)
TABLE 248 Rest of Middle East and Africa Peripheral Artery Disease Market, By Distribution Channel, 2017-2022(US$ Bn)
TABLE 249 Rest of Middle East and Africa Peripheral Artery Disease Market, By Distribution Channel, 2023-2030(US$ Bn)

Frequently Asked Questions

What is the current size of the global peripheral artery disease market?

The global peripheral artery disease market was valued at USD 3.9 Billion in 2022.

What is the expected growth rate of the peripheral artery disease market between 2023 and 2030?

The peripheral artery disease market is expected to grow at a CAGR of 8.80% between 2023 and 2030, reaching USD 7.0 Billion in 2030.

Which segment is leading the market share in terms of End-Users?

Hospitals have a market share of approximately 60.4% in 2022.

Which route of administration segment governs the demand for peripheral artery diseases in the world?

The oral segment is the market’s most popular and in-demand segment.

Which segment is expected to post the highest CAGR during the forecast period?

the catheter segment is anticipated to expand at a rapid CAGR.

Which region is fueling the growth of the peripheral artery disease industry?

North America will command a share of almost 40% of the market for Peripheral Artery Disease market (PAD)

Who are the major players in the global peripheral artery disease market?

The top players include Bayer AG, Abbott, Boston Scientific Corporation and BIOTRONIK. Other major players include AngioDynamics, Koninklijke Philips NV, Cook, Medtronic and Cardinal Health.

What are the major market drivers of the peripheral artery disease industry?

Increased Geriatric Population and Better Insurance and Reimbursement Policies are the major market drivers.

What are the major market restraints of the peripheral artery disease industry?

Treatment is costly, and there is underdiagnosis and a lack of awareness are the major market restraints.

What are the major market opportunities of the peripheral artery disease industry?

Increasing desire for non-invasive treatment options and advancements in medical technology are the major opportunities in the peripheral artery disease industry.

AI in Wound Care Market

Published:
Report ID: 40725

Antibiotics Market

Published:
Report ID: 40728

Conjugation and Labeling Services Market

Published:
Report ID: 40756

Antiviral Drugs Market

Published:
Report ID: 40681

AI in Oncology Market

Published:
Report ID: 40668

Automated Liquid Handling Systems Market

Published:
Report ID: 40663

Non Infectious Macular Edema Treatment Market

Published:
Report ID: 7337

U.S. Medical Device Contract Manufacturing Market

Published:
Report ID: 40557

Endoscopes Market

Published:
Report ID: 40551

Animal Wound Care Market

Published:
Report ID: 40564

Adeno Associated Viral Vector Market

Published:
Report ID: 40601

AI Based Drug Discovery Market

Published:
Report ID: 40608

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN